Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/v13050804 http://scihub22266oqcxt.onion/10.3390/v13050804 33946201!8145721!33946201     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Viruses 2021 ; 13 (5): ä Nephropedia Template TP {{tp|p=33946201|t=2021. Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country |pdf=|usr=}}{{33946201}} gab.com Text Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country JO: Viruses http://www.kidney.de/pget.php?&tw=1&pmid=33946201 #FOAvip It is unclear whether universal PCR screening for SARS-CoV-2 in asymptomatic individuals prior to admission is useful. From April to December 2020, the positive rate of universal pre-admission screening was 0.005% (4/76,521) in a tertiary care hospital in Korea. The positive rates were not different between the periods (period 1 (daily new patients of <1 per million inhabitants) vs. period 2 (1-8.3 per million inhabitants) vs. period 3 (10.3 to 20 per million inhabitants); P = 0.45). Universal pre-admission screening for SARS-CoV-2 had a lower positive rate than that of symptom-based screening (0.005% vs. 0.049% (53/109,257), p < 0.001). In addition, seven patients with negative pre-admission test results had subsequent positive PCR during hospitalization, and four patients had secondary transmission. Universal pre-admission PCR screening may not be practical in settings of low prevalence of COVID-19, and negative PCR results at admission should not serve as a basis for underestimating the risk of nosocomial spread from asymptomatic patients. Twit Text FOAVip Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country ????Viruses http://www.kidney.de/pget.php?&tw=1&pmid=33946201 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33946201 #FOAvip English Wikipedia <ref>{{Cite pmid|33946201}}</ref> Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country #MMPMID33946201 Jung J; Kim J; Lim JS; Kim EO; Kim MN; Kim SH Viruses 2021[Apr]; 13 (5): ä PMID33946201show ga It is unclear whether universal PCR screening for SARS-CoV-2 in asymptomatic individuals prior to admission is useful. From April to December 2020, the positive rate of universal pre-admission screening was 0.005% (4/76,521) in a tertiary care hospital in Korea. The positive rates were not different between the periods (period 1 (daily new patients of <1 per million inhabitants) vs. period 2 (1-8.3 per million inhabitants) vs. period 3 (10.3 to 20 per million inhabitants); P = 0.45). Universal pre-admission screening for SARS-CoV-2 had a lower positive rate than that of symptom-based screening (0.005% vs. 0.049% (53/109,257), p < 0.001). In addition, seven patients with negative pre-admission test results had subsequent positive PCR during hospitalization, and four patients had secondary transmission. Universal pre-admission PCR screening may not be practical in settings of low prevalence of COVID-19, and negative PCR results at admission should not serve as a basis for underestimating the risk of nosocomial spread from asymptomatic patients. |*COVID-19/diagnosis/epidemiology[MESH] |*Carrier State/diagnosis/epidemiology[MESH] |Asymptomatic Diseases/*epidemiology[MESH] |COVID-19 Nucleic Acid Testing/*methods[MESH] |Humans[MESH] |Nasopharynx/*virology[MESH] |Prevalence[MESH] |Republic of Korea/epidemiology[MESH] |SARS-CoV-2/*isolation & purification[MESH]Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low P(epmc).pdf DeepDyve Pubget Overpricing